Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer

Oncotarget

Volumn 4, Issue 5, 2013, Pages 739-750

  Wang, Xiao Yang ^a   Yu, Huina ^b   Linnoila, R Ilona ^a   Li, Laodong ^b   Li, Dangyu ^b   Mo, Biwen ^b   Okano, Hideyuki ^c   Penalva, Luiz O F ^d   Glazer, Robert I ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GUILIN MEDICAL UNIVERSITY   (China)

^c KEIO UNIVERSITY   (Japan)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

Author keywords

Lung cancer; Musashi1; Notch; Numb; ShRNA; catenin

Indexed keywords

BETA CATENIN; CD133 ANTIGEN; MESSENGER RNA; MUSASHI1; NOTCH RECEPTOR; SHORT HAIRPIN RNA; TUMOR MARKER; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; AGED; ARTICLE; BRONCHUS BIOPSY; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOMA CELL; CELL NUCLEUS; CELL POPULATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULARLY TARGETED THERAPY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENSITIVITY AND SPECIFICITY; SPHEROID CELL; TISSUE MICROARRAY; TUMOR SPHEROID;

EID: 84880274346     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1034     Document Type: Article

References (43)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90.
2. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29.
3. El-Bayoumi E and Silvestri GA. Bronchoscopy for the diagnosis and staging of lung cancer. Seminars in respiratory and critical care medicine. 2008; 29(3):261-270.
4. Maldonado F and Jett JR. Advances in the diagnosis of lung cancer: contribution of molecular biology to bronchoscopic diagnosis. Curr Opin Pulm Med. 2010; 16(4):315-320.
5. Wigle DA. Personalized therapy for non-small cell lung cancer: hype or clinical reality? Semin Thorac Cardiovasc Surg. 2011; 23(1):30-35.
6. Herbst RS and Lippman SM. Molecular signatures of lung cancer--toward personalized therapy. N Engl J Med. 2007; 356(1):76-78.
7. Yu T, Zhao LN, Lan SY, Fan MJ, Gong Y, Shi L, Yuan YH, Huang KH and Chen QK. Musashi1 expression cells derived from mouse embryonic stem cells can be enriched in side population isolated by fluorescence activated cell sorter. BMC cell biology. 2011; 12:47.
8. Glazer RI, Wang XY, Yuan H and Yin Y. Musashi1: a stem cell marker no longer in search of a function. Cell cycle. 2008; 7(17):2635-2639.
9. Glazer RI, Vo DT and Penalva LO. Musashi1: an RBP with versatile functions in normal and cancer stem cells. Front Biosci. 2012; 17:54-64.
10. Okano H, Kawahara H, Toriya M, Nakao K, Shibata S and Imai T. Function of RNA-binding protein Musashi-1 in stem cells. Exp Cell Res. 2005; 306(2):349-356.
11. Galante PA, Sandhu D, de Sousa Abreu R, Gradassi M, Slager N, Vogel C, de Souza SJ and Penalva LO. A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue: Identification of potential players in tumor formation. RNA biology. 2009; 6(4):426-433.
12. Imai T, Tokunaga A, Yoshida T, Hashimoto M, Mikoshiba K, Weinmaster G, Nakafuku M and Okano H. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol Cell Biol. 2001; 21(12):3888-3900.
13. Battelli C, Nikopoulos GN, Mitchell JG and Verdi JM. The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1. Mol Cell Neurosci. 2006; 31(1):85-96.
14. Kawahara H, Imai T, Imataka H, Tsujimoto M, Matsumoto K and Okano H. Neural RNA-binding protein Musashi1 inhibits translation initiation by competing with eIF4G for PABP. J Cell Biol. 2008; 181(4):639-653.
15. Horisawa K, Imai T, Okano H and Yanagawa H. 3'-Untranslated region of doublecortin mRNA is a binding target of the Musashi1 RNA-binding protein. FEBS Lett. 2009; 583(14):2429-2434.
16. Kuwako K, Kakumoto K, Imai T, Igarashi M, Hamakubo T, Sakakibara S, Tessier-Lavigne M, Okano HJ and Okano H. Neural RNA-binding protein Musashi1 controls midline crossing of precerebellar neurons through posttranscriptional regulation of Robo3/Rig-1 expression. Neuron. 2010; 67(3):407-421.
17. Spears E and Neufeld KL. Novel double-negative feedback loop between adenomatous polyposis coli and Musashi1 in colon epithelia. J Biol Chem. 2011; 286(7):4946-4950.
18. de Sousa Abreu R, Sanchez-Diaz PC, Vogel C, Burns SC, Ko D, Burton TL, Vo DT, Chennasamudaram S, Le SY, Shapiro BA and Penalva LO. Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes. J Biol Chem. 2009; 284(18):12125-12135.
19. Wang T, Ong CW, Shi J, Srivastava S, Yan B, Cheng CL, Yong WP, Chan SL, Yeoh KG, Iacopetta B and Salto-Tellez M. Sequential expression of putative stem cell markers in gastric carcinogenesis. Br J Cancer. 2011; 105(5):658-665.
20. Liu DC, Yang ZL and Jiang S. Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Cancer biomarkers : section A of Disease markers. 2010; 8(3):113-121.
21. Fan LF, Dong WG, Jiang CQ, Xia D, Liao F and Yu QF. Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas. Int J Colorectal Dis. 2010; 25(1):17-23.
22. Gotte M, Wolf M, Staebler A, Buchweitz O, Kelsch R, Schuring AN and Kiesel L. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma. J Pathol. 2008; 215(3):317-329.
23. Moreira AL, Gonen M, Rekhtman N and Downey RJ. Progenitor stem cell marker expression by pulmonary carcinomas. Mod Pathol. 2010; 23(6):889-895.
24. Wang XY, Penalva LO, Yuan H, Linnoila RI, Lu J, Okano H and Glazer RI. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Molecular cancer. 2010; 9:221-232.
25. Wang XY, Yin Y, Yuan H, Sakamaki T, Okano H and Glazer RI. Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways. Mol Cell Biol. 2008; 28(11):3589- 3599.
26. Sanchez-Diaz PC, Burton TL, Burns SC, Hung JY and Penalva LO. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy. BMC cancer. 2008; 8:280.
27. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A. 2009; 106(38):16281-16286.
28. Pine SR, Ryan BM, Varticovski L, Robles AI and Harris CC. Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci U S A. 2010; 107(5):2195-2200.
29. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De Maria R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008; 15(3):504- 514.
30. McGill MA, Dho SE, Weinmaster G and McGlade CJ. Numb regulates post-endocytic trafficking and degradation of Notch1. J Biol Chem. 2009; 284(39):26427-26438.
31. McGill MA and McGlade CJ. Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem. 2003.
32. Gordon MD and Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem.
33. Gu Y, Fu J, Lo PK, Wang S, Wang Q and Chen H. The effect of B27 supplement on promoting in vitro propagation of Her2/neu-transformed mammary tumorspheres. Journal of Biotech Research. 2011; 3:7-18.
34. Ravindran G and Devaraj H. Aberrant expression of CD133 and musashi-1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors. Head Neck. 2012; 34(8):1129- 1135.
35. Vo DT, Subramaniam D, Remke M, Burton TL, Uren PJ, Gelfond JA, de Sousa Abreu R, Burns SC, Qiao M, Suresh U, Korshunov A, Dubuc AM, Northcott PA, Smith AD, Pfister SM, Taylor MD, et al. The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis. Am J Pathol. 2012; 181(5):1762-1772.
36. Muto J, Imai T, Ogawa D, Nishimoto Y, Okada Y, Mabuchi Y, Kawase T, Iwanami A, Mischel PS, Saya H, Yoshida K, Matsuzaki Y and Okano H. RNA-binding protein Musashi1 modulates glioma cell growth through the posttranscriptional regulation of Notch and PI3 kinase/Akt signaling pathways. PloS one. 2012; 7(3):e33431.
37. Vo DT, Abdelmohsen K, Martindale JL, Qiao M, Tominaga K, Burton TL, Gelfond JA, Brenner AJ, Patel V, Trageser D, Scheffler B, Gorospe M and Penalva LO. The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells. Molecular cancer research : MCR. 2012; 10(1):143-155.
38. Li D, Peng X, Yan D, Tang H, Huang F, Yang Y and Peng Z. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer. Ann Surg Oncol. 2011; 18(7):2074- 2083.
39. Sureban SM, May R, George RJ, Dieckgraefe BK, McLeod HL, Ramalingam S, Bishnupuri KS, Natarajan G, Anant S and Houchen CW. Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo. Gastroenterology. 2008; 134(5):1448-1458.
40. Nishimoto Y and Okano H. New insight into cancer therapeutics: induction of differentiation by regulating the Musashi/Numb/Notch pathway. Cell Res. 2010; 20(10):1083-1085.
41. Rezza A, Skah S, Roche C, Nadjar J, Samarut J and Plateroti M. The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation. J Cell Sci. 2010; 123(Pt 19):3256-3265.
42. Katoh M and Katoh M. NUMB is a break of WNT-Notch signaling cycle. Int J Mol Med. 2006; 18(3):517-521.
43. Kaneko Y, Sakakibara S, Imai T, Suzuki A, Nakamura Y, Sawamoto K, Ogawa Y, Toyama Y, Miyata T and Okano H. Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci. 2000; 22(1-2):139-153.